Therapeutic targeting of chromatin alterations in leukemia and solid tumors
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner +7 more
wiley +1 more source
Adherence to the acceleration of total postoperative recovery protocol and perioperative complications in cancer patients. [PDF]
Albanese SPR +5 more
europepmc +1 more source
Tumores mamarios en felinos domésticos. Epidemiología, criterios de diagnóstico y enfoque terapéutico [PDF]
Cattaneo U., Gino, Flores P., Estefanía
core +1 more source
DNA methyltransferase inhibitors in hematological malignancies and solid tumors
Abstract Epigenetic modifications such as DNA methylation play a fundamental role in oncogenesis and the progression of neoplasms neoplasias. DNA methyltransferase inhibitors (DNMTi) constitute a family of therapeutic agents that impede the methylation at the 5‐position on cytosine nucleotides, thereby modulating the epigenetic regulation of tumor ...
Valentin Wenger +3 more
wiley +1 more source
Effect of MisMatch repair deficiency on metastasis occurrence in a syngeneic mouse model. [PDF]
Laplante P +7 more
europepmc +1 more source
Advancing cancer research via comparative oncology. [PDF]
Vincze O +10 more
europepmc +1 more source
Cervical Cancer Biomarkers in Non-Cervical Samples: Emerging Tools for Diagnosis and Prognosis. [PDF]
Lizarazo-Taborda MDR +5 more
europepmc +1 more source
Mitogenomic Alterations in Breast Cancer: Identification of Potential Biomarkers of Risk and Prognosis. [PDF]
Pérez-Amado CJ +10 more
europepmc +1 more source

